http://apps.who.int/iris/handle/10665/64464

It addresses the extra considerations that may not be covered by standard drug-procurement procedures, as special and imperative issues for vaccines, procurement cycle, and responsibility of the procurement entity. Document in pdf format; Acrobat Reader required.A version in Russian is available.